Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1407942782
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
560 Meyerland Plaza Mall
Houston, TX, 77096
Phone (713) 442-3222
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,264
1,501 services
Medicare patients, 2024
12
Average age 72
Drug cost, 2024
$1.9M
7,479 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tri R Lee prescribed most often to Medicare patients was Levothyroxine Sodium, with 709 prescriptions and refills. In total Tri R Lee wrote 7,479 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 709 | 1,972 | 206 | $2,253 |
| Ozempic Semaglutide | 463 | 579 | 95 | $540K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 359 | 663 | 90 | $233K |
| Jardiance Empagliflozin | 257 | 402 | 60 | $230K |
| Metformin Hcl Generic | 241 | 681 | 75 | $3,829 |
| Metformin Hcl Er Metformin Hcl | 225 | 603 | 74 | $4,033 |
| Methimazole Generic | 216 | 452 | 51 | $2,674 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 206 | 398 | 79 | $17K |
| Glimepiride Generic | 196 | 534 | 57 | $6,088 |
| Glipizide Generic | 181 | 473 | 56 | $2,905 |
| Farxiga Dapagliflozin Propanediol | 176 | 242 | 38 | $132K |
| Novolog Flexpen Insulin Aspart | 173 | 378 | 67 | $40K |
| Atorvastatin Calcium Generic | 172 | 456 | 55 | $4,335 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 160 | 380 | 45 | $891 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 139 | 202 | 27 | $50K |
Brand drugs: 2,668 claims; generic drugs: 4,403 claims; opioid claims: 12.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tri R Lee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.